8 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Phase II Study of Trastuzumab Deruxtecan (T-DXd) Plus Pyrotinib in HER2-Positive Advanced Breast Cancer After Progression on T-DXdNeoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorderNot yet recruitingPhase 22026-09-23NCT07836257
A I/II Phase Clinical Study to Evaluate the Safety and Efficacy of RC288 in the Treatment of Solid TumorsSolid TumorsRecruitingPhase 1 / Phase 22026-09-23NCT07537881
Umbilical Cord Stem Cells for Skin Grafts in Donor Site WoundsCicatrix, Hypertrophic, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, severe cutaneous adverse reactionRecruitingNot applicable2026-09-03NCT05984628
A Phase Ib/II Study of SYS6090 Combination Therapy in Advanced Colorectal CancerDigestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorderNot yet recruitingPhase 1 / Phase 22026-08-06NCT07750041
Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacokinetics, and Preliminary Efficacy of FS-8002Advanced Solid TumorsRecruitingPhase 12026-08-04NCT06832982
A Multimodal Convergent Cohort of Parkinson's Disease at FJMUUH (FJMUUH-PD): Natural History StudyParkinson disease, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, synucleinopathyNot yet recruitingNot stated2026-05-15NCT07588763
Dyadic Personalized Home-Based Activity Program for Mild-to-Moderate Dementia Patients Post-Dischargebrain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, psychiatric disorderRecruitingNot applicable2026-05-11NCT07081750
An IIT Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of a Single Intrathecal Injection of SNUG01 in Patients with Amyotrophic Lateral SclerosisNutritional and Metabolic Diseases, TDP-43 proteinopathy, amyotrophic lateral sclerosis, central nervous system disorder, metabolic disease, motor neuron disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, proteostasis deficiencies, spinal cord disorderNot yet recruitingEarly phase 12024-10-16NCT06645197